Showing results (1271-1280 of 1,886) with videos related to
Sort By:
Pageof 189
Cardiovascular Diabetology|April 8, 2016
Cohort profile: the German Diabetes Study (GDS)Julia Szendroedi, Aaruni Saxena, Katharina S Weber, et al.Physical Review Letters|March 5, 2016
Signatures of the Self-Similar Regime of Strongly Coupled Stimulated Brillouin Scattering for Efficient Short Laser Pulse AmplificationL Lancia, A Giribono, L Vassura, et al.Cardiovascular Diabetology|June 9, 2025
Characterizing trajectories of diabetes-related health parameters before diabetes diagnosis in diabetes subtypes: analysis of a 20-year long prospective cohort study in SwedenTatjana P Liedtke, Eike A Strathmann, Emma Ahlqvist, et al.Environmental Toxicology and Chemistry|February 16, 2016
Bioaccessibility tests accurately estimate bioavailability of lead to quailW Nelson Beyer, Nicholas T Basta, Rufus L Chaney, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2023
A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor ResistanceAnkita Mitra, Brian Thompson, Ann Strange, et al.Archives of Otolaryngology--Head & Neck Surgery|December 22, 2010
Quality and performance indicators in an academic department of head and neck surgeryRandal S Weber, Carol M Lewis, Scott D Eastman, et al.Annals of Surgery|October 1, 1993
The development of gene therapy for the treatment of cancerS A Rosenberg, W F Anderson, M Blaese, et al.International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck CancerDavid I Rosenthal, Abdallah S R Mohamed, Adam S Garden, et al.Nature Medicine|August 7, 2007
Type II monocytes modulate T cell-mediated central nervous system autoimmune diseaseMartin S Weber, Thomas Prod'homme, Sawsan Youssef, et al.Drugs|November 20, 2008
Disease-modifying agents for multiple sclerosis: recent advances and future prospectsTil Menge, Martin S Weber, Bernhard Hemmer, et al.Pageof 189